GGrantIndex
Sort

17,054 grants matching genome editing

Oncofetal TNC CAR T Cell Therapy for Pediatric Sarcoma

$42,752
Elizabeth Wickman · St. Jude Children'S Research Hospital Graduate School Of Biomedical Sciences, Llc · F31 · FY2022 · CA

Understanding gene regulation in schizophrenia-associated loci using high-throughput epigenetic CRISPR screens

$42,690
Marisa C. Hamilton · Duke University · F31 · FY2025 · MH

Dissecting the role of disease-associated variants in the regulation of TMEM106B

$42,676
Michael D Gallagher · University Of Pennsylvania · F31 · FY2014 · NS

Investigating the mechanism of infection and therapeutic potential of Pseudomonas nucleus-forming phages

$42,664
Chase Morgan · University Of California, San Diego · F30 · FY2025 · AI

Import of double-stranded RNA and cholesterol into cells in C. elegans

$42,547
Victoria Lowers · Univ Of Maryland, College Park · F31 · FY2024 · HL

Understanding gene regulation in schizophrenia-associated loci using high-throughput epigenetic CRISPR screens

$42,519
Marisa C. Hamilton · Duke University · F31 · FY2024 · MH

Restoring Vision with High-Fidelity Nonsense Codon Correction

$42,500
Bikash Ranjan Pattnaik · University Of Wisconsin-Madison · R24 · FY2022 · EY

Restoring Vision with High-Fidelity Nonsense Codon Correction

$42,500
Bikash Ranjan Pattnaik · University Of Wisconsin-Madison · R24 · FY2021 · EY

Discovering disease-causal variants by linking genetic and epigenetic variation

$42,497
Luca Pinello · Dana-Farber Cancer Inst · K99 · FY2016 · HG

Novel genetic engineering tools for functional studies of the gut microbiome

$42,486
Sway Peng Chen · Columbia University Health Sciences · F30 · FY2017 · DK

Effects of early Retinoic Acid signaling on valve development

$42,479
Andrew Theodore David Fernandes · Cincinnati Childrens Hosp Med Ctr · F31 · FY2025 · HL

A Patient-Specific hiPSC Model of Nilotinib-Induced Peripheral Artery Disease Pharmacogenomics

$42,459
Emily Pinheiro · Northwestern University At Chicago · F31 · FY2022 · HL

Equipment Supplement: Genomic and Systemic Approaches of Evolutionary Mechanisms

$42,390
Jianzhi Zhang · University Of Michigan At Ann Arbor · R35 · FY2023 · GM

Deciphering unintended large gene modifications in gene editing for sickle cell disease

$42,336
Gang Bao · Rice University · R01 · FY2024 · HL

Elucidating the Role of the Thousand and One Kinases in Retinal Ganglion Cell Death

$42,334
Sean Chapman · University Of California, San Diego · F30 · FY2025 · EY

WORKSHOP: Science, Ethics, and Justice: Reconsiderations and New Directions.

$42,304
Laura A Mamo · San Francisco State University · · FY2010 · SBE

Deciphering Mechanisms of Early Human Hematoendothelial Development.

$42,288
Mathew Angelos · University Of Minnesota · F30 · FY2017 · DK

Hypoxia-Induced Misdirection: Understanding Postnatal Inhibitory Interneuron Migration in Neonatal Hypoxic Injury

$42,284
Aunoy Poddar · University Of California, San Francisco · F31 · FY2025 · NS

Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response

$42,274
Redwan Bhuiyan · University Of Connecticut Sch Of Med/Dnt · F30 · FY2022 · DK

Investigating the role of DISC1 using iPSCs from patients with mental disorders

$42,232
Ha Nam Nguyen · Johns Hopkins University · F31 · FY2013 · MH

Identifying the Determinants of Immunoediting During Glioblastoma Immunotherapy

$42,220
Jack Ghannam · Harvard Medical School · F30 · FY2025 · CA

Adoptive Cell Therapy with Rejuvenated Antigen-specific T Cells

$42,206
Fumito Ito · University Of Michigan At Ann Arbor · K08 · FY2015 · CA

Determining the genetic drivers of ancestry-specific differential penetrance of APOE4 in sporadic Alzheimer’s Disease

$42,138
Zachary A Gardell · University Of California, San Francisco · F31 · FY2025 · AG

U-RISE at Florida Atlantic University

$42,039
Alex C Keene · Florida Atlantic University · T34 · FY2020 · GM

Mouse Genome Engineering Core Facility

$42,036
Channabasavaiah Gurumurthy · University Of Nebraska Medical Center · P30 · FY2018 · GM